Arcturus Therapeutics Ltd. Proceeds from Stock Options Exercised
Arcturus Therapeutics Ltd. reported Proceeds from Stock Options Exercised of $332.00 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-18.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2019-05-13
- Arcturus Therapeutics Ltd. proceeds from stock options exercised for the quarter ending 2018-12-31 was $0.00, a 100.00% decline year-over-year.
- Arcturus Therapeutics Ltd. proceeds from stock options exercised for the quarter ending 2018-09-30 was -$19.00K, a 106.51% decline year-over-year.
- Arcturus Therapeutics Ltd. proceeds from stock options exercised for the quarter ending 2018-06-30 was $57.00K.
- Arcturus Therapeutics Ltd. proceeds from stock options exercised for the quarter ending 2018-03-31 was $294.00K.
- Arcturus Therapeutics Ltd. proceeds from stock options exercised for fiscal 2018 was $332.00K, a 53.31% decline from fiscal 2017.
- Arcturus Therapeutics Ltd. proceeds from stock options exercised for fiscal 2017 was $711.00K.
| Period end | Proceeds from Stock Options Exercised 3 month | Proceeds from Stock Options Exercised 6 month | Proceeds from Stock Options Exercised 9 month | Proceeds from Stock Options Exercised 12 month | Proceeds from Stock Options Exercised 12 month as first filed | Proceeds from Stock Options Exercised 71 month |
|---|---|---|---|---|---|---|
| 2018-12-31 | $0.00 derived: 10-K 12 month − 6-K 9 month · filed 2019-03-18 | -$19.00K derived: sum of 2 quarters · filed 2019-03-18 | $38.00K derived: sum of 3 quarters · filed 2019-03-18 | $332.00K 10-K · filed 2019-03-18 | ||
| 2018-09-30 | -$19.00K derived: 6-K 9 month − 6-K 6 month · filed 2018-11-07 | $38.00K derived: sum of 2 quarters · filed 2018-11-07 | $332.00K 6-K · filed 2018-11-07 | $751.00K derived: sum of 4 quarters · filed 2019-05-13 | ||
| 2018-06-30 | $57.00K derived: 6-K 6 month − 10-Q 3 month · filed 2018-09-28 | $351.00K 6-K · filed 2018-09-28 | $770.00K derived: sum of 3 quarters · filed 2019-05-13 | $1.06M derived: sum of 4 quarters · filed 2019-05-13 | ||
| 2018-03-31 | $294.00K 10-Q · filed 2019-05-13 | $713.00K derived: sum of 2 quarters · filed 2019-05-13 | $1.00M derived: sum of 3 quarters · filed 2019-05-13 | |||
| 2017-12-31 | $419.00K derived: 10-K 12 month − 6-K 9 month · filed 2019-03-18 | $711.00K derived: sum of 2 quarters · filed 2019-03-18 | $711.00K 10-K · filed 2019-03-18 | |||
| 2017-09-30 | $292.00K derived: 6-K 9 month − 6-K 6 month · filed 2018-11-07 | $292.00K 6-K · filed 2018-11-07 | ||||
| 2017-06-30 | $0.00 6-K · filed 2018-09-28 | |||||
| 2016-12-31 | $6.00K 20-F · filed 2017-04-28 | |||||
| 2015-12-31 | $17.00K 20-F · filed 2018-05-14 | $13.00K 20-F · filed 2016-03-04 | ||||
| 2014-12-31 | $0.00 20-F · filed 2017-04-28 | |||||
| 2013-12-31 | $29.00K 20-F · filed 2016-03-04 | $29.00K 20-F · filed 2014-03-28 | ||||
| 2012-12-31 | $0.00 20-F · filed 2015-02-27 | |||||
| 2011-12-31 | $0.00 20-F · filed 2014-03-28 |